Correction to: VEGF 165 b, a splice variant of VEGF-A, promotes lung tumor progression and escape from anti-angiogenic therapies through a β1 integrin/VEGFR autocrine loop.
Asma BoudriaCherine Abou FaycalTao JiaStephanie GoutMichelle KeramidasChloé DidierNicolas LemaîtreSandra ManetJean-Luc CollAnne-Claire ToffartDenis Moro-SibilotCorinne Albiges-RizoVéronique JosserandEva FaurobertChristian BrambillaElisabeth BrambillaSylvie GazzeriBeatrice EyminPublished in: Oncogene (2023)